tirzepatide gip analog Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Frontiers | Clinical perspectives on

Many men find significant relief from joint pain and other symptoms after starting therapy, allowing them to move more freely and live with less discomfort

Sedentary individuals typically need far fewer infusions than competitive athletes

Gallstone formation appeared in a small percentage of rapid weight losers (related to fat mobilization rather than the drug itself), and kidney function remained stable in participants with normal baseline renal health

Borgundvaag, E., Mak, J

Many prescribers tell patients to "drink in moderation," which is underspecified

10.2147/jpr.S283782 119 ZhangF.ZhouY.ChenH.JiangH.ZhouF.LvB.et al (2022)